YD Bio Limited (NASDAQ:YDES) Short Interest Update

YD Bio Limited (NASDAQ:YDES) was the recipient of a significant increase in short interest in the month of September. As of September 15th, there was short interest totaling 42,960 shares, an increase of 223.2% from the August 31st total of 13,293 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average trading volume of 619,936 shares, the days-to-cover ratio is currently 0.1 days.

Institutional Investors Weigh In On YD Bio

An institutional investor recently raised its stake in YD Bio stock. Cypress Capital Management LLC WY boosted its stake in shares of YD Bio Limited (NASDAQ:YDES) by 9.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 33,690 shares of the biotechnology company’s stock after purchasing an additional 3,000 shares during the quarter. Cypress Capital Management LLC WY’s holdings in YD Bio were worth $76,000 at the end of the most recent quarter.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of YD Bio to a “hold” rating in a research report on Saturday. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, YD Bio has a consensus rating of “Sell”.

YD Bio Stock Up 20.1%

YDES stock traded up $0.96 during midday trading on Friday, reaching $5.73. The company had a trading volume of 653,908 shares, compared to its average volume of 663,906. YD Bio has a 1 year low of $1.70 and a 1 year high of $22.00. The company has a 50 day moving average of $3.32 and a two-hundred day moving average of $4.19.

YD Bio (NASDAQ:YDES) last issued its quarterly earnings data on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter. The business had revenue of $0.42 million during the quarter.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.